Filing Details
- Accession Number:
- 0001209191-21-031355
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-05-10 13:00:00
- Reporting Period:
- 2021-05-06
- Accepted Time:
- 2021-05-10 17:43:46
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1761612 | Bicycle Therapeutics Plc | BCYC | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1776938 | Kevin Lee | C/O Bicycle Therapeutics Plc B900, Babraham Research Campus Cambridge X0 CB22 3AT | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2021-05-06 | 1,716 | $14.00 | 256,450 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2021-05-06 | 1,716 | $32.14 | 254,734 | No | 4 | S | Direct | |
| Ordinary Shares | Acquisiton | 2021-05-07 | 5,604 | $14.00 | 260,338 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2021-05-07 | 5,604 | $32.23 | 254,734 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Stock Option (right to buy) | Disposition | 2021-05-06 | 1,716 | $0.00 | 1,716 | $14.00 |
| Ordinary Shares | Stock Option (right to buy) | Disposition | 2021-05-07 | 5,604 | $0.00 | 5,604 | $14.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 420,148 | 2029-06-28 | No | 4 | M | Direct | |
| 414,544 | 2029-06-28 | No | 4 | M | Direct |
Footnotes
- Shares sold pursuant to a Rule 10b5-1 trading plan.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.00 to $32.50 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3).
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.00 to $32.76 inclusive.
- This option shall vest in 36 equal monthly installments at the end of each calendar month following the date of the grant.
Billionaire Hedge Funds
